The Affordable Care Act (better known as "Obamacare") has completely rearranged the healthcare chessboard and left many wanting, frustrated and confused, especially now that its future has become less clear. And I think it's safe to say that the real beneficiaries of the ACA have been the insurance companies.
As Washington tries to remedy the problems, we are still stuck with the No. 1 problem: How can we deliver low-cost healthcare to middle income families that are being buried with high insurance premiums and a scant provider network that changes year to year?
---Sponsored Link--- IRA/401(k) ALERT: Secret IRS Loophole Will Save Your LifeEvery day the US creeps further into debt and its taking your IRA/401K along with it. At the time of this writing the national debt was $20.5 trillion. Yes, you read that right. There is a simple and legal IRS loophole that can protect your IRA/401K without spending a penny. All you have to do is request the guide below to see how this IRS Loophole works. Download your FREE IRS Loophole Guide.
One solution that would make sense is for a national clinic and pharmacy to merge with an insurance company. This is exactly what the proposed CVS (NYSE: CVS)/Aetna (NYSE: AET) merger would provide. Not only would this merger be a good thing for a large segment of the American populous, it will certainly be a good thing for CVS.
Hot Penny Stocks For 2019: Transocean Inc.(RIG)
Advisors' Opinion:- [By Jim Crumly]
As for individual stocks, Amazon.com (NASDAQ:AMZN) briefly broke through $1 trillion in valuation, and Transocean Ltd. (NYSE:RIG) announced plans to acquire Ocean Rig UDW (NASDAQ:ORIG).
- [By Dan Caplinger]
The stock market was mixed on Friday, with the Dow Jones Industrial Average climbing to record heights even as the Nasdaq Composite gave back some of its recent gains. Investors largely continued to play a waiting game, as little in the way of new economic data or readings on the geopolitical environment impeded generally bullish sentiment. Whenever stocks reach lofty heights, pauses are inevitable, but some were nevertheless able to climb higher. Transocean (NYSE:RIG), Novavax (NASDAQ:NVAX), and Steelcase (NYSE:SCS) were among the best performers on the day. Here's why they did so well.
- [By Jason Hall and Tyler Crowe]
In this week's episode of Industry Focus: Energy, host Nick Sciple, together with Jason Hall and Tyler Crowe, explain how offshore companies work, where the industry is today, and what investors should watch with these companies. Tune in to learn what sets Transocean (NYSE:RIG), Diamond Offshore (NYSE:DO), Seadrill (NYSE:SDRL), and Ensco (NYSE:ESV) apart from each other, what kind of risk/reward profile each company has to offer, some critical points and trends investors need to know before diving into offshore, and much more.
- [By Ethan Ryder]
D.B. Root & Company LLC acquired a new position in shares of Transocean (NYSE:RIG) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 30,040 shares of the offshore drilling services provider’s stock, valued at approximately $297,000.
- [By Jason Hall, Tyler Crowe, and John Bromels]
According to three Motley Fool contributors, there are still ample opportunities to profit in the oil and gas segment as some left-behind subsectors start to catch up to the higher price trend. Three in particular that are well-positioned going forward are Transocean LTD (NYSE:RIG), National-Oilwell Varco, Inc. (NYSE:NOV), and Devon Energy Corp (NYSE:DVN).
- [By Paul Ausick]
Offshore drilling services company Transocean Ltd. (NYSE: RIG) announced Tuesday that it has agreed to acquire competitor Ocean Rig UDW Inc. (NASDAQ: ORIG) in a deal valued at $2.7 billion. Transocean will pay approximately $2.7 billion for Ocean Rig, including $12.75 and 1.6128 shares of newly issued Transocean stock for each share of Ocean Rig.
Hot Penny Stocks For 2019: Patni Computer Systems Limited(PTI)
Advisors' Opinion:- [By Chris Lange]
Proteostasis Therapeutics Inc. (NASDAQ: PTI) saw its shares slide early on Thursday after the company reported that it had positive data from its early stage trial in cystic fibrosis (CF). These results come from the firm's ongoing Phase 1 dosing study of PTI-801 in CF patients on background Orkambi (lumacaftor/ivacaftor) therapy.
Hot Penny Stocks For 2019: Jinpan International Limited(JST)
Advisors' Opinion:- [By Joseph Griffin]
Warburg Research set a €47.00 ($55.95) price target on JOST Werke (ETR:JST) in a report published on Friday. The firm currently has a buy rating on the stock.
- [By Logan Wallace]
A number of firms have modified their ratings and price targets on shares of JOST Werke (ETR: JST) recently:
5/25/2018 – JOST Werke was given a new €46.00 ($53.49) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock. 5/25/2018 – JOST Werke was given a new €46.00 ($53.49) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock. 5/25/2018 – JOST Werke was given a new €47.00 ($54.65) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock. 5/24/2018 – JOST Werke was given a new €45.00 ($52.33) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock. 5/8/2018 – JOST Werke was given a new €46.00 ($53.49) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock. 4/4/2018 – JOST Werke was given a new €47.00 ($54.65) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.Shares of JOST Werke traded down €0.15 ($0.17), hitting €38.10 ($44.30), during mid-day trading on Friday, according to MarketBeat. 8,510 shares of the company’s stock were exchanged, compared to its average volume of 35,469. JOST Werke AG has a 52 week low of €27.20 ($31.63) and a 52 week high of €47.50 ($55.23).
- [By Joseph Griffin]
JOST Werke AG (ETR:JST) has earned an average rating of “Buy” from the six research firms that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is €49.33 ($57.36).
- [By Max Byerly]
Hauck & Aufhaeuser set a €58.00 ($67.44) target price on JOST Werke (ETR:JST) in a report issued on Wednesday. The brokerage currently has a buy rating on the stock.
- [By Joseph Griffin]
Deutsche Bank set a €46.00 ($53.49) price target on JOST Werke (ETR:JST) in a research report sent to investors on Friday. The firm currently has a buy rating on the stock.
Hot Penny Stocks For 2019: SORL Auto Parts Inc.(SORL)
Advisors' Opinion:- [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results. LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat. MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900. SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results. Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat. Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday. Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday. PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results. Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy. Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat. Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
- [By Stephan Byrd]
Icahn Enterprises LP Common Stock (NASDAQ: SORL) and Sorl Auto Parts (NASDAQ:SORL) are both multi-sector conglomerates companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.
- [By Lisa Levin]
Shares of SORL Auto Parts, Inc. (NASDAQ: SORL) got a boost, shooting up 13 percent to $5.90 after reporting upbeat Q1 results.
Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares were also up, gaining 24 percent to $27.3947 following Q3 results.
- [By Lisa Levin] Gainers Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results. MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58. Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82. Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82. Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings. Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69. PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42. LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results. Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results. Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37. Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
No comments:
Post a Comment